Sulfonamides and cotrimoxazole are antibacterial drugs that work by inhibiting folic acid synthesis. Sulfonamides are classified based on half-life as short, intermediate, or long acting. Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim that has synergistic antibacterial effects. These drugs are used to treat infections like toxoplasmosis, UTIs, nocardiosis, and pneumocystis pneumonia. Common adverse effects include nausea, crystalluria, rashes, and hemolytic anemia in G6PD deficiency.
Bactrim D.S. (Sulfamethoxazole and Trimethoprim Tablets)The Swiss Pharmacy
?
Bactrim D.S. (Sulfamethoxazole and Trimethoprim Tablets) is indicated in adults and pediatric patients two months of age and older for treatment of infections caused by designated, susceptible bacteria.
The indications include urinary tract infections, acute otitis media in pediatric patients, acute exacerbations of chronic bronchitis, treatment of travelers’ diarrhea, treatment of enteritis, treatment of documented Pneumocystis carinii pneumonia and prophylaxis against Pneumocystis carinii pneumonia in individuals who are immunosuppressed.
Sulfonamides were the first effective antimicrobials against bacterial infections. Sulfonamides and their derivatives work by inhibiting the bacterial enzyme dihydropteroate synthetase, blocking the synthesis of folic acid which is essential for bacteria. Cotrimoxazole is a fixed combination drug of sulfamethoxazole and trimethoprim that has enhanced activity through synergistic inhibition of two sequential steps in bacterial folic acid synthesis. It has a broader antibacterial spectrum and lower resistance than sulfonamides alone. Common uses include urinary tract infections, respiratory infections, typhoid, and Pneumocystis pneumonia prophylaxis in AIDS patients. Adverse effects include hypersensitivity reactions, blood
Sulfonamides were the first effective antibacterial agents discovered in the 1930s and were widely used before the development of penicillin. While now largely replaced by other antibiotics, they continue to have therapeutic uses. Key points include: sulfonamides work by inhibiting folic acid biosynthesis; they are excreted renally so dosage should be adjusted for renal impairment; and trimethoprim-sulfamethoxazole is a commonly used combination that is synergistic and has expanded antimicrobial activity. Adverse effects can include allergic reactions and hematological effects like anemia.
Sulfadiazine is a synthetic sulphonamide derivative that acts as a competitive inhibitor of p-aminobenzoic acid in the folic acid metabolism cycle of bacteria, inhibiting their multiplication. It is readily absorbed orally but parenteral administration is difficult due to its alkaline nature. Sulfadiazine is widely distributed throughout tissues, achieving high levels in fluids like the pleural, peritoneal, synovial and ocular fluids. It is used in combination with pyrimethamine to treat toxoplasmosis in AIDS patients and newborns with congenital infections.
This document discusses several classes of antibacterial drugs including penicillins, cephalosporins, macrolides, tetracyclines, aminoglycosides, fluoroquinolones, and sulfonamides. It provides information on their history, uses, mechanisms of action, common drugs in each class, dosages, side effects, and nursing considerations. Penicillins and cephalosporins are beta-lactam antibiotics that are effective against certain gram-positive and gram-negative bacteria. It is important for patients to finish their full antibiotic course and be aware of potential drug interactions and side effects like allergic reactions.
Sulfonamides were the first antibacterial agents discovered with prontosil. They are effective against many bacterial infections but resistance emerged quickly. Their current use is limited except in combination with trimethoprim or pyrimethamine. Sulfonamides work by inhibiting bacterial folate synthase. They have varied absorption and excretion profiles and are used for infections like pneumonia, UTIs, and toxoplasmosis when combined with other drugs. Adverse effects include nausea, rashes, and blood abnormalities.
This document discusses sulfonamides and trimethoprim, which are synthetic antibacterial drugs. It explains their mechanism of action by inhibiting the enzyme dihydrofolate reductase and blocking the biosynthesis of nucleic acids. Some examples are mentioned, along with their absorption, half-life, uses and adverse effects. Synergism when used together is also noted. Brand names of some common sulfonamide and trimethoprim/sulfamethoxazole combination drugs are provided at the end.
The document discusses sulfonamides, including their discovery by Gerhard Domagk, modes of classification based on duration of action, pharmacokinetics, chemistry, and mechanisms of action. It also covers their therapeutic uses such as for urinary tract infections, respiratory infections, and combinations including cotrimoxazole and triple sulfa.
The document discusses a group project on sulfonamides. It includes information on various sulfonamide drugs including trimethoprim, cotrimoxazole, sulfasalazine, and sulfadiazine. For each drug, it summarizes the mechanism of action, pharmacokinetics, uses, and adverse effects. It also discusses resistance to sulfonamides and future goals in developing new molecules that target the pterin binding site rather than the PABA binding site targeted by current sulfonamides.
Antifungal drugs are used to treat and prevent fungal infections. There are several classes of antifungal drugs including polyenes, echinocandins, azoles, and others. Azole resistance can develop through mechanisms such as decreased drug concentration due to efflux pumps, target site alterations of the ERG11 gene, and bypassing of the ergosterol pathway. Amphotericin B works by binding to ergosterol in the fungal cell membrane. Ketoconazole inhibits the enzyme lanosterol 14α-demethylase. Antifungal drugs can cause side effects and are also used to treat specific fungal infections.
This document summarizes various antibiotics that inhibit cell wall synthesis, including glycopeptides like vancomycin, dalbavancin, telavancin, teicoplanin, and ramoplanin. It also discusses the lipopeptide daptomycin and other antibiotics such as bacitracin, fosfomycin, and cycloserine. The antibiotics covered are primarily effective against gram-positive cocci and are commonly used to treat methicillin-resistant Staphylococcus aureus (MRSA), skin and soft tissue infections, and pseudomembranous colitis.
Sulfonamides are synthetic antimicrobial agents that act as structural analogues of para-amino benzoic acid (PABA), an important component in bacterial folic acid synthesis. Sulfonamides compete with PABA for the bacterial enzyme dihydropteroic acid synthetase, forming nonfunctional folic acid analogues that inhibit bacterial growth. Common sulfonamide drugs include sulfadiazine, sulfamethoxazole, and sulfadoxine. Cotrimoxazole is a synergistic combination of sulfamethoxazole and trimethoprim that inhibits two sequential steps in bacterial folic acid synthesis. Sulfonamides are selectively toxic to bacteria due to differences in human and bacterial
1. Sulfonamides and co-trimoxazole are antimicrobial agents that work by inhibiting folic acid synthesis in bacteria.
2. Co-trimoxazole is a synergistic combination of sulfamethoxazole and trimethoprim that blocks sequential steps in the folic acid pathway.
3. Common uses include urinary tract infections, respiratory infections, toxoplasmosis, and pneumocystis pneumonia prophylaxis in HIV/AIDS patients. Adverse effects include allergic reactions and crystalluria.
Sulfonamides were the first effective antimicrobial agents against bacterial infections. They work by inhibiting the bacterial enzyme involved in folic acid synthesis. While sulfonamides were widely used, resistance emerged rapidly and newer antibiotics proved safer and more effective. Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim that causes sequential blockade of folate metabolism and has activity against a wide range of bacteria. It is commonly used for urinary tract infections, respiratory infections, and Pneumocystis pneumonia in AIDS patients. Adverse effects are similar to those of sulfonamides and include nausea, rash, and bone marrow suppression in high risk groups.
- Sulfonamide is a class of antibacterial medications derived from p-aminobenzene sulfonamide. They act as competitive inhibitors of p-amino benzoic acid in the bacterial folic acid synthesis pathway.
- Sulfonamide was the first antibacterial discovered in the 1930s and ushered in the "sulfur drug era". It works by interfering with the production of folic acid which is essential for bacterial cell division and growth.
- Cotrimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that provides broad-spectrum antibacterial activity. It is commonly used to treat urinary tract infections, respiratory infections, and Pneumoc
This word document deals with summarized drug profile of cotrimoxazole. Important pharmacological headings, along with important counselling tips and drug catchpoints have also been elucidated.
This document discusses anti-amoebic agents used to treat infections caused by the protozoa Entamoeba histolytica. It classifies anti-amoebic drugs into tissue amoebicides and luminal amoebicides. Metronidazole is the prototype nitroimidazole tissue amoebicide used to treat both intestinal and extraintestinal amoebiasis. Other nitroimidazoles discussed include tinidazole, secnidazole, and ornidazole. Diloxanide furoate is a luminal amoebicide that directly kills trophozoites responsible for cyst production in the intestines. Combination drugs containing diloxanide furoate
This document summarizes information about sulphonamides, including their classification, mechanism of action, pharmacokinetics, uses, and adverse effects. Sulphonamides were the first effective chemotherapeutic agents used to treat bacterial infections. They work by competitively inhibiting the bacterial enzyme dihydropteroate synthase, blocking the synthesis of folic acid and DNA. Different sulphonamides have short, intermediate, or long durations of action depending on their absorption and excretion rates. While systemic use is now rare, sulphonamides combined with trimethoprim or used topically to prevent infections remain important. Adverse effects can include nausea, crystalluria, and hypersensitivity reactions.
This document discusses tetracycline antibiotics. It notes that tetracyclines reversibly bind to the 30S ribosome and inhibit aminoacyl-tRNA binding. They are broad spectrum antibiotics active against most bacteria except Proteus and Pseudomonas. Resistance can develop through decreased cell permeability, increased drug efflux, ribosomal protection, or enzymatic inactivation. Common tetracyclines include doxycycline, minocycline and tetracycline itself. Adverse effects include gastrointestinal issues, renal impairment, hepatotoxicity and tooth discoloration in children. Drug interactions and contraindications are also discussed.
Sulfonamides and trimethoprim are antibacterial drugs that work by inhibiting bacterial folic acid synthesis. Sulfonamides were the first antibacterial sulfone drugs discovered in the 1930s. Trimethoprim inhibits a different enzyme in the folic acid pathway. The combination of sulfamethoxazole and trimethoprim is highly synergistic and known as cotrimoxazole. It is used to treat urinary tract, respiratory, and other infections. Both drugs can cause side effects like rash, nausea, and bone marrow suppression if not used carefully, especially in pregnancy, renal impairment, or the elderly.
Folic acid inhibitors work by interfering with the synthesis of folic acid in bacteria, which is necessary for bacterial protein synthesis and growth. The document discusses sulfonamides and trimethoprim as two major classes of folic acid inhibitors. Sulfonamides are classified based on absorption and effects, with some being rapidly absorbed from the gut while others are poorly absorbed but active in the bowel. Trimethoprim selectively inhibits bacterial dihydrofolic acid reductase. Both have antimicrobial effects but work better in combination, with sulfamethoxazole and trimethoprim being a commonly used synergistic combination as co-trimoxazole.
Sulphonamides and their combination with trimethoprim - by Dr.Jibachha SahDr. Jibachha Sah
?
Sulphonamides and their combination with trimethoprim is lecturer notes on Veterinary Pharmacology & Toxicology(Chemotherapy) for B.V.Sc & A.H students of veterinary college.
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha SahDr. Jibachha Sah
?
Lecturer notes on veterinary pharmacology and toxicology for B.V.Sc & A.H Seventh semester student for educational purpose.This lecturer notes will be useful for all the veterinary students.Plesae send your comments,jibachhashah@gmail.com,mob.9845024121
Sulfonamides , Co-trimoxazole , urinary anti septicJeenaJoy10
?
This document discusses sulfonamides, cotrimoxazole, and urinary antiseptics. It provides information on the classification, mechanism of action, pharmacokinetics, uses, and adverse effects of sulfonamides. It also summarizes the rationale for combining trimethoprim and sulfamethoxazole in cotrimoxazole, its mechanism of action and uses. Finally, it classifies drugs used for urinary tract infections and provides details on nitrofurantoin, nalidixic acid, and methenamine mandelate which are commonly used urinary antiseptics.
The document discusses folic acid synthesis inhibitors, which are drugs that interfere with the synthesis of folic acid in bacteria. It describes several classes of these drugs, including sulfonamides and diaminopyrimidines. Sulfonamides competitively inhibit the enzyme dihydropteroate synthase, blocking the synthesis of folic acid. Co-trimoxazole is highlighted as an effective combination of sulfamethoxazole and trimethoprim that inhibits both folic acid synthesis and reduction.
Sulfonamides were the first effective antimicrobial agents against bacterial infections. They work by interfering with bacterial synthesis of folate and are classified based on duration of action and therapeutic use. Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim that is bactericidal due to synergistic inhibition of dihydrofolate reductase. It has improved spectrum and resistance compared to the individual components. Common adverse effects include nausea, vomiting, and headache.
This document discusses sulfonamides and trimethoprim, which are synthetic antibacterial drugs. It explains their mechanism of action by inhibiting the enzyme dihydrofolate reductase and blocking the biosynthesis of nucleic acids. Some examples are mentioned, along with their absorption, half-life, uses and adverse effects. Synergism when used together is also noted. Brand names of some common sulfonamide and trimethoprim/sulfamethoxazole combination drugs are provided at the end.
The document discusses sulfonamides, including their discovery by Gerhard Domagk, modes of classification based on duration of action, pharmacokinetics, chemistry, and mechanisms of action. It also covers their therapeutic uses such as for urinary tract infections, respiratory infections, and combinations including cotrimoxazole and triple sulfa.
The document discusses a group project on sulfonamides. It includes information on various sulfonamide drugs including trimethoprim, cotrimoxazole, sulfasalazine, and sulfadiazine. For each drug, it summarizes the mechanism of action, pharmacokinetics, uses, and adverse effects. It also discusses resistance to sulfonamides and future goals in developing new molecules that target the pterin binding site rather than the PABA binding site targeted by current sulfonamides.
Antifungal drugs are used to treat and prevent fungal infections. There are several classes of antifungal drugs including polyenes, echinocandins, azoles, and others. Azole resistance can develop through mechanisms such as decreased drug concentration due to efflux pumps, target site alterations of the ERG11 gene, and bypassing of the ergosterol pathway. Amphotericin B works by binding to ergosterol in the fungal cell membrane. Ketoconazole inhibits the enzyme lanosterol 14α-demethylase. Antifungal drugs can cause side effects and are also used to treat specific fungal infections.
This document summarizes various antibiotics that inhibit cell wall synthesis, including glycopeptides like vancomycin, dalbavancin, telavancin, teicoplanin, and ramoplanin. It also discusses the lipopeptide daptomycin and other antibiotics such as bacitracin, fosfomycin, and cycloserine. The antibiotics covered are primarily effective against gram-positive cocci and are commonly used to treat methicillin-resistant Staphylococcus aureus (MRSA), skin and soft tissue infections, and pseudomembranous colitis.
Sulfonamides are synthetic antimicrobial agents that act as structural analogues of para-amino benzoic acid (PABA), an important component in bacterial folic acid synthesis. Sulfonamides compete with PABA for the bacterial enzyme dihydropteroic acid synthetase, forming nonfunctional folic acid analogues that inhibit bacterial growth. Common sulfonamide drugs include sulfadiazine, sulfamethoxazole, and sulfadoxine. Cotrimoxazole is a synergistic combination of sulfamethoxazole and trimethoprim that inhibits two sequential steps in bacterial folic acid synthesis. Sulfonamides are selectively toxic to bacteria due to differences in human and bacterial
1. Sulfonamides and co-trimoxazole are antimicrobial agents that work by inhibiting folic acid synthesis in bacteria.
2. Co-trimoxazole is a synergistic combination of sulfamethoxazole and trimethoprim that blocks sequential steps in the folic acid pathway.
3. Common uses include urinary tract infections, respiratory infections, toxoplasmosis, and pneumocystis pneumonia prophylaxis in HIV/AIDS patients. Adverse effects include allergic reactions and crystalluria.
Sulfonamides were the first effective antimicrobial agents against bacterial infections. They work by inhibiting the bacterial enzyme involved in folic acid synthesis. While sulfonamides were widely used, resistance emerged rapidly and newer antibiotics proved safer and more effective. Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim that causes sequential blockade of folate metabolism and has activity against a wide range of bacteria. It is commonly used for urinary tract infections, respiratory infections, and Pneumocystis pneumonia in AIDS patients. Adverse effects are similar to those of sulfonamides and include nausea, rash, and bone marrow suppression in high risk groups.
- Sulfonamide is a class of antibacterial medications derived from p-aminobenzene sulfonamide. They act as competitive inhibitors of p-amino benzoic acid in the bacterial folic acid synthesis pathway.
- Sulfonamide was the first antibacterial discovered in the 1930s and ushered in the "sulfur drug era". It works by interfering with the production of folic acid which is essential for bacterial cell division and growth.
- Cotrimoxazole is a fixed-dose combination of sulfamethoxazole and trimethoprim that provides broad-spectrum antibacterial activity. It is commonly used to treat urinary tract infections, respiratory infections, and Pneumoc
This word document deals with summarized drug profile of cotrimoxazole. Important pharmacological headings, along with important counselling tips and drug catchpoints have also been elucidated.
This document discusses anti-amoebic agents used to treat infections caused by the protozoa Entamoeba histolytica. It classifies anti-amoebic drugs into tissue amoebicides and luminal amoebicides. Metronidazole is the prototype nitroimidazole tissue amoebicide used to treat both intestinal and extraintestinal amoebiasis. Other nitroimidazoles discussed include tinidazole, secnidazole, and ornidazole. Diloxanide furoate is a luminal amoebicide that directly kills trophozoites responsible for cyst production in the intestines. Combination drugs containing diloxanide furoate
This document summarizes information about sulphonamides, including their classification, mechanism of action, pharmacokinetics, uses, and adverse effects. Sulphonamides were the first effective chemotherapeutic agents used to treat bacterial infections. They work by competitively inhibiting the bacterial enzyme dihydropteroate synthase, blocking the synthesis of folic acid and DNA. Different sulphonamides have short, intermediate, or long durations of action depending on their absorption and excretion rates. While systemic use is now rare, sulphonamides combined with trimethoprim or used topically to prevent infections remain important. Adverse effects can include nausea, crystalluria, and hypersensitivity reactions.
This document discusses tetracycline antibiotics. It notes that tetracyclines reversibly bind to the 30S ribosome and inhibit aminoacyl-tRNA binding. They are broad spectrum antibiotics active against most bacteria except Proteus and Pseudomonas. Resistance can develop through decreased cell permeability, increased drug efflux, ribosomal protection, or enzymatic inactivation. Common tetracyclines include doxycycline, minocycline and tetracycline itself. Adverse effects include gastrointestinal issues, renal impairment, hepatotoxicity and tooth discoloration in children. Drug interactions and contraindications are also discussed.
Sulfonamides and trimethoprim are antibacterial drugs that work by inhibiting bacterial folic acid synthesis. Sulfonamides were the first antibacterial sulfone drugs discovered in the 1930s. Trimethoprim inhibits a different enzyme in the folic acid pathway. The combination of sulfamethoxazole and trimethoprim is highly synergistic and known as cotrimoxazole. It is used to treat urinary tract, respiratory, and other infections. Both drugs can cause side effects like rash, nausea, and bone marrow suppression if not used carefully, especially in pregnancy, renal impairment, or the elderly.
Folic acid inhibitors work by interfering with the synthesis of folic acid in bacteria, which is necessary for bacterial protein synthesis and growth. The document discusses sulfonamides and trimethoprim as two major classes of folic acid inhibitors. Sulfonamides are classified based on absorption and effects, with some being rapidly absorbed from the gut while others are poorly absorbed but active in the bowel. Trimethoprim selectively inhibits bacterial dihydrofolic acid reductase. Both have antimicrobial effects but work better in combination, with sulfamethoxazole and trimethoprim being a commonly used synergistic combination as co-trimoxazole.
Sulphonamides and their combination with trimethoprim - by Dr.Jibachha SahDr. Jibachha Sah
?
Sulphonamides and their combination with trimethoprim is lecturer notes on Veterinary Pharmacology & Toxicology(Chemotherapy) for B.V.Sc & A.H students of veterinary college.
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha SahDr. Jibachha Sah
?
Lecturer notes on veterinary pharmacology and toxicology for B.V.Sc & A.H Seventh semester student for educational purpose.This lecturer notes will be useful for all the veterinary students.Plesae send your comments,jibachhashah@gmail.com,mob.9845024121
Sulfonamides , Co-trimoxazole , urinary anti septicJeenaJoy10
?
This document discusses sulfonamides, cotrimoxazole, and urinary antiseptics. It provides information on the classification, mechanism of action, pharmacokinetics, uses, and adverse effects of sulfonamides. It also summarizes the rationale for combining trimethoprim and sulfamethoxazole in cotrimoxazole, its mechanism of action and uses. Finally, it classifies drugs used for urinary tract infections and provides details on nitrofurantoin, nalidixic acid, and methenamine mandelate which are commonly used urinary antiseptics.
The document discusses folic acid synthesis inhibitors, which are drugs that interfere with the synthesis of folic acid in bacteria. It describes several classes of these drugs, including sulfonamides and diaminopyrimidines. Sulfonamides competitively inhibit the enzyme dihydropteroate synthase, blocking the synthesis of folic acid. Co-trimoxazole is highlighted as an effective combination of sulfamethoxazole and trimethoprim that inhibits both folic acid synthesis and reduction.
Sulfonamides were the first effective antimicrobial agents against bacterial infections. They work by interfering with bacterial synthesis of folate and are classified based on duration of action and therapeutic use. Cotrimoxazole is a combination of sulfamethoxazole and trimethoprim that is bactericidal due to synergistic inhibition of dihydrofolate reductase. It has improved spectrum and resistance compared to the individual components. Common adverse effects include nausea, vomiting, and headache.
The document discusses sulfonamides, which are antibacterial drugs that work by inhibiting folic acid synthesis in bacteria. It describes their mechanism of action, examples of specific sulfonamide drugs like sulfamethoxazole, and their use to treat conditions like urinary tract infections, pneumonia, and toxoplasmosis. It also covers trimethoprim-sulfamethoxazole combination therapy and potential adverse effects like rash, nausea, and blood disorders that can occur with sulfonamide use.
1. The document discusses sulfonamides, which are synthetic antibacterial drugs derived from sulfanilamide.
2. It covers the history, chemistry, mechanisms of action, spectrum of activity, pharmacokinetics, clinical uses and toxicity of sulfonamides.
3. Sulfonamides work by competing with para-aminobenzoic acid to inhibit bacterial synthesis of folic acid, which is essential for DNA synthesis. They have broad-spectrum activity against many gram-positive and gram-negative bacteria.
This document discusses smoking cessation and pharmacological and non-pharmacological therapies for smoking cessation. It then discusses various pharmacological therapies for chronic obstructive pulmonary disease (COPD) including nicotine replacement products, varenicline, bupropion, inhaled corticosteroids, methylxanthines, and phosphodiesterase 4 inhibitors. It provides details on drug mechanisms of action, dosages, side effects, and efficacy evidence. Non-pharmacological therapies like pulmonary rehabilitation and various surgical interventions for COPD are also summarized.
This page contains my portfolio data and career journey, which consists of: introduction, educational background, internship experience and organizational experience.
Top Human Resource Job Skills Employers Are Seeking in 2025.pptxvinay salarite
?
As the job market evolves, employers are seeking HR professionals with advanced skills in HR technology, talent acquisition, employee engagement, and workforce analytics. Staying ahead in 2025 requires mastering remote workforce management, DEI strategies, and conflict resolution. Whether you're an experienced HR leader or an aspiring professional, developing these skills can unlock top HR jobs in Jaipur and beyond.
Ready to enhance your HR career? Join Salarite today and explore the best job opportunities in HR!
Visit Salarite’s Official Website & Apply Now!
New Wondershare UniConverter Crack Free Download (Latest 2025)am2612067
?
https://crackedios.com/after-verification-click-go-to-download-page/
UniConverter - Best Video Converter Ultimate. Convert, Download, Compress, Edit, Burn Videos in 1000 formats, and do more. This program allows you to customize home movies through advanced editing features and get professional-looking works in minutes. Download or record your favorite 4K/HD videos from popular video-sharing sites for enjoyment without an Internet connection. Or convert them to compatible formats for playback on TV, smartphone, or other devices. This powerful DVD toolkit of UniConverter (originally Wondershare Video Converter Ultimate) helps you to create and edit DVD files easily.
https://crackedios.com/after-verification-click-go-to-download-page/
Part-Time Jobs in Jaipur for Students and Working Professionals.pptxvinay salarite
?
Jaipur offers diverse part-time job opportunities for students and working professionals in retail, IT, hospitality, and education. Flexible work options make it easier to balance studies or full-time jobs while gaining valuable experience.
Explore opportunities now and start your career!
Engage is FSU College of Social Sciences and Public Policy’s annual magazine for alumni and friends.
Each edition contains highlights from the college’s many student, faculty, staff, and alumni achievements during that academic year.
I served as Editor-in-Chief and Creative Director for this project, which included all graphic design services.
Title of the Proposal
Abstract
Introduction and Background
Research Questions and Objectives
Methodology
Significance and Implications
Timeline
Budget
Conclusion
Rerefences
I am the Director of Communications for Florida State University's College of Social Sciences and Public Policy (COSSPP).
I have a strong track record of developing and implementing strategic and creative marketing approaches that incorporate expertise in public relations, graphic design, and digital marketing strategies.
In my role as Communications Director for COSSPP, I have the pleasure of communicating with our current and prospective students, faculty, staff, alumni, friends, and the communities beyond impacted by our work. COSSPP is home to 12 departments and interdisciplinary programs and 11 centers and institutes and serves as the third largest College at FSU, helping more than 5,000 students each year along their academic journeys. Our 50,000+ alumni work around the globe to address the world’s challenges and to better their communities. To support this work, I run an internship program within our College and provide on-the-job learning opportunities to FSU students at the undergraduate and graduate levels. Our students develop skills critical for workplace readiness and leave with comprehensive portfolios showcasing their writing, design, photography, and project management skills.
2. Learning Outcome
At the end of the session student
should be able to:
?Classify the Sulfonamides.
?Explain the mechanism of action,
therapeutic uses, adverse effects* of
clinically useful Sulfonamides
?Explain the rationale of combination of
sulfamethoxazole and Trimethoprim in
Cotrimoxazole
Sulfonamides/ SSRMC/2020
2
3. ? First antimicrobial agent effective
against pyogenic bacterial
infection
? Scientist-DOMAGK
? PRONTOSIL RED
DYE 3
8. SPECTRUM
Both gram positive and gram negative
Bacteriostatic.
Eg.s.pyogenes,s.pneumonia,H.influenza,H.ducreyi,
nocardia,actinomyces.
MIC(minimum inhibitory conc) range from
0.1microg/ml (C.trachomatosis ) to 4-64 micg/ml for
E.coli.
9. PHARMACOKINETICS
Abs:70-100% orally absorbed
sulfonamides can be found in urine within 30 mins
peak plasma levels 2-6hrs
major site:SI>Stomach
bound to albumin
Dis:throughout all the tissues and body fluids
crosses placenta and cause both antibacterial
and troxic effects.
10. Cont..
Metabolism:Liver
Acetylation
metabolic derivative(N4 acetylated sulfonamide)
Excretion:excreted in urine
t1/2 (depends on renal function)
In acid urine,the older sulfonamides are insoluble
and may ppt ,forming crystalline deposits tat can
cause urinary obs.
Small amounts-feces,bile,milk and other secretion.
11. ? Toxoplasmosis – Combination of
sulfadiazine
& Pyrimethamine is DOC .
? Urinary tract infection – Due to appearance
of resistant organism , no longer therapy of
first choice.
- Co-trimoxazole ,Fluoroquinolones are
preferred drugs.
? Nocardiasis- Sulfadiazine may be given 6-8
gm daily.
? P. falciparum malaria- 3 tab stat of
Sulfadoxine (500mg ) + Pyrimethamine
(25mg) Sulfonamides/ SSRMC/2020 1
12. ? To prevent burn infection – Silver
sulfadiazine 1% cream
? In Ulcerative colitis – Sulfasalazine in dose
of 3-4 gm /day induces remission for few
weeks. Maintance therapy 1.5-2 gm is
required.
? Trachoma- Sulfacetamide Sod. as eye drops
& eye ointment. Systemic therapy with
tetracycline is preferred.
? Preventing of Streptococcal infection &
recurrence of Rheumatic fever- Used in
who are sensitive to Penicillin.Sulfonamides/ SSRMC/2020 1
13. ? 1.Nausea , vomiting , epigastric pain
? 2.Crystalluria is dose related
? Advice- Alkalization of urine increases
pH?solubility of sulfonamide
increased.
? Plenty of fluid – daily urine volume in
adult at least 1200 ml.
? 3. Hypersensitivity reactions
? Rashes , urticaria,& drug fever
Sulfonamides/ SSRMC/2020 10
14. ? Characterized by distinctive iris or target
lesions ,acrally distributed & associated
with sore throat.
? Target lesions include three zones: an erythematous
or dusky small central papule that may form blister, a
raised edematous middle ring, and an erythematous
outer ring.
Sulfonamides/ SSRMC/2020 14
15. ? More severe than Erythema Multiforme
?characterized by Dusky or Purpuric
Macules, erosion of mucous membrane
& blister in <10% of total body surface
area
Dusky or Purpuric
MaculeTypical of
Stevens-Johnson Syndrome.
Macules may
coalesce to form
blisters.
Sulfonamides/ SSRMC/2020 15
Ulceration & erytherma
of
Oral mucous membrane
& lips
16. Or Lyells syndrome > 30 % of body
surface area.
?7. Hemolysis in dose dependent
in G- 6-PD deficiency patients.
8.Kernicterus may precipitate in
premature neonate , by displacement
of bilirubin from plasma protein
binding site.
?9. Hepatitis
Sulfonamides/ SSRMC/2020 16
18. ? The resistant mutants either:
-Produced increase amount of PABA.
-Dihydropteroate synthase enzyme
has low affinity for sulfonamide.
Sulfonamides/ SSRMC/2020 18
19. ? Combination of sulfamethoxazole(400mg) with
Trimethoprim (80 mg) – 5:1 Ratio
?Combination preferred due to
? MOA- Individual compounds are
bacteriostatic
- combination become bactericidal due to
sequential blockade of folate metabolism.
- STUDENTS +TEACHER
15
20. ? To achieve optimum synergism
-absorption &Excretion characteristics are
similar
-Half life sulfamethaoxazole – 10 hrs
Trimethoprim – 11 hrs
-Trimethoprim more widely distributed in
tissue than sulfamethaoxazole
? To reduce bacterial resistance.
Sulfonamides/ SSRMC/2020 20
21. ? Trimethoprim 80 mg
Sulfonamides/ SSRMC/2020 21
+ 0ral or Inj/5ml
? Sulfamethoxazole 400 mg
= Co-trimoxazole
? Dose – 2 tab or double strength (DS) of
single tab given twice daily for 10 –14
days for management of most
infection
22. ? Megaloblastic anemia occur in
patient with marginal folate level
? Hemolytic anemia may develop
individual with G6PD deficiency
? Stevens –Johnson syndrome & Lyell’s
syndrome can occur.
Sulfonamides/ SSRMC/2020 22
23. ? Nausea, vomiting, stomatitis,
headache, rashes
? Patient with renal disease may develop
uremia
? Fever, bone marrow hypoplasia in AIDS
patients with Pneumocystis jiroveci
? Diuretics along with cotrimoxazole-
thrombocytopenia
Sulfonamides/ SSRMC/2020 23
24. ? Urinary tract infection (UTI)
?single dose of 4 tab of Co – trimoxazole
Sulfonamides/ SSRMC/2020 20
T/t for acute cystitis or Uncomplicated UTI
? Prostatitis has good value - 4-6
weeks T/t
? Bacterial respiratory tract infection
? Effective in acute otitis media in children
& acute maxillary sinusitis caused by H.
influenza
? Streptococcal pharyngitis– does not
eradicatestreptococcus
25. ? Typhoid fever – Now DOC
Ciprofloxacin/ Cephalosporins
?Used as alternative in patients not
tolerating Fluroquinolones
?Bacterial diarrhoea & dysentry
Fluoroquinolone is better drugs
?Chancroid – Co-trimoxazole 2 tabs
BD for 5-7 days is DOC.
?Pneumocystis joroveci- severe
pneumoniaSulfonamides/ SSRMC/2020 21
26. Sulfonamides/ SSRMC/2020
Sulfo
namides
Mechanism of
Action Uses Adverse
effects
1.Orally
absorbable:
Sulfadiazine,
Sulfamethoxazole
,Sulfamoxole,
Sulfadoxine,
Sulfamethopyrazi
ne
2.Oral non
absorbable –
Sulfasalazine
3.Topical
Mafenide,
Sulfacetamide,
Silver sulfadiazine
Special Purpose
Sulfonamides
Group 2 & 3
? Bacteriostatic
in nature
? Toxoplasmosis
? Urinary tract
infection
? Nocardiasis
? P. falciparum
malaria
? To prevent burn
infection – Silver
sulfadiazine*
1% cream
? In Ulcerative
colitis –
Sulfasalazine
? Trachoma
? Preventing of
Streptococcal
infection &
recurrence of
Rheumatic fever
? Nausea, vomiting,
epigastric pain
?Crystalluria
?Hypersensitivity
reaction-
Rashes, urticaria,
drug fever
?Erythema
multiforme
?Steven Johnson
syndrome
?Toxic epidermal
necrolysis
?Hemolysis in
G6PD deficiency
patient
?Kernicterus
27. Cotrimoxazole
Sulfonamides/ SSRMC/2020
Mechanism
ofAction
Uses Adverse
effects
Combination of
sulfamethoxaz
ole (400 mg) +
Trimethoprim
(80 mg) – 5:1
Ratio
Individual
compounds-
bacteriostatic
combination
becomes
bactericidal
due to
sequential
blockade of
folate
metabolism
( Show with a
flow chart)
? Urinary tract infection
(UTI)
? Bacterial respiratory
tract infection
? Typhoid fever
? Bacterial diarrhoea &
dysentry
? Chancroid
? Megaloblastic
anemia
? Hemolytic
anemia may
develop
individual with
G6PD deficiency
? Stevens –
Johnson syndrome
& Lyell’s
syndrome